Austin Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.76M Buy
3,253
+103
+3% +$122K 0.5% 22
2026
Q2
$3.78M Hold
3,150
– – 0.53% 22
2026
Q1
$2.9M Sell
3,150
-184
-6% -$187K 0.48% 23
2025
Q4
$3.58M Sell
3,334
-281
-8% -$269K 0.59% 20
2025
Q3
$2.76M Sell
3,615
-70
-2% -$52.1K 0.5% 21
2025
Q2
$2.87M Sell
3,685
-49
-1% -$38.1K 0.56% 21
2025
Q1
$3.08M Buy
+3,734
New +$3.11M 0.64% 22

Other funds holding LLY

Austin Asset Management's LLY Position: Q3 2026 in Review

Austin Asset Management increased its Eli Lilly (LLY) stake by 3.3% in Q3 2026, buying an estimated $122K and bringing the position to 3,253 shares worth $3.76M. The position accounts for 0.5% of the portfolio, ranked #22.

Austin Asset Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.78M in Q2 2026. 2,991 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Austin Asset Management held 3,253 shares of Eli Lilly worth $3.76M as of Q3 2026.
  • Austin Asset Management bought 103 Eli Lilly shares in Q3 2026, an estimated $122K.
  • Eli Lilly made up 0.5% of Austin Asset Management's portfolio in Q3 2026, its #22 holding.
  • Austin Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • Austin Asset Management's Eli Lilly position peaked at $3.78M in Q2 2026.
  • 2,991 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Austin Asset Management's 13F filing for Q3 2026, filed 29 Oct 2026.